Access Bio Accused Of Breaching $120M COVID Test Kit Deal

By Bonnie Eslinger (January 19, 2022, 7:14 PM EST) -- Intrivo Diagnostics Inc. slapped the maker of its COVID-19 tests with a breach of contract suit that accuses Access Bio Inc. of reneging on a $120 million production and distribution deal while creating a "virtually identical" test that competes with its product....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!